2026 Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine (AIPM)
About
AIPM 2026 Comes to the West Coast! Join Global Leaders in AI and Pharmaceutical Medicine at UC Berkeley The Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine (AIPM) is coming to the UC Berkeley on October 13–14, 2026 for its first West Coast gathering. This forum will bring together leaders from academia, industry, government, and regulatory organizations to explore the opportunities and challenges shaping the future of AI in pharmaceutical medicine, including AI-driven drug development, clinical trials, real-world evidence, causal inference, and responsible AI. Featuring experts from organizations including Pfizer, Genentech, Amgen, Stanford University, UC Berkeley, and beyond, AIPM 2026 offers a unique opportunity to connect, collaborate, and advance the future of AI-enabled healthcare innovation.Learn more:https://ww2.amstat.org/meetings/aipm/2026/index.cfm (https://ww2.amstat.org/meetings/aipm/2026/index.cfm)Register Here:https://ww2.amstat.org/me
